Nuveen Credit Opportunities 2022 Target Term Fund JCO
Set alert
As of May 25, 3:41 PM ET
- Open
- 7.94
- Prev close
- 7.95
- Mkt cap
- 220.81M
- Vol
- 38.34K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.94
- High
- 7.96
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.95
- 200-d avg
- 7.95
News
5 months ago gurufocus.com
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
RYBREVANT FASPRO⢠(amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where
12 months ago defenseworld.net
Daily Journal Corp. (S.C.) (NASDAQ:DJCO) and American Community Newspapers (OTCMKTS:ACNI) Critical Review
American Community Newspapers (OTCMKTS:ACNI - Get Free Report) and Daily Journal Corp. (S.C.) (NASDAQ: DJCO - Get Free Report) are both consumer staples companies, but which is the superior…
2 years ago prnewswire.com
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
Data Support Clinical Performance of Galleri to Detect More Aggressive Prostate Cancers MENLO PARK, Calif. , Aug. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose…
2 years ago prnewswire.com
Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
SAN FRANCISCO and SUZHOU, China , June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and…
2 years ago prnewswire.com
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
SAN FRANCISCO, U.S. and SUZHOU, China , June 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and…
2 years ago globenewswire.com
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1
4 years ago businesswire.com
Nuveen Credit Opportunities 2022 Target Term Fund Announces Termination and Liquidation
NEW YORK--(BUSINESS WIRE)--The Nuveen Credit Opportunities 2022 Target Term Fund (NYSE: JCO) completed its termination and liquidation following the close of business on June 1, 2022. The termination…
4 years ago businesswire.com
Nuveen Credit Opportunities 2022 Target Term Fund Declares Special Distribution
NEW YORK--(BUSINESS WIRE)--Nuveen today announced that the Nuveen Credit Opportunities 2022 Target Term Fund (NYSE: JCO) declared a special income distribution. The following dates apply to today’s…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
4 years ago businesswire.com
Nuveen Credit Opportunities 2022 Target Term Fund Announces Liquidation Details
NEW YORK--(BUSINESS WIRE)--The Nuveen Credit Opportunities 2022 Target Term Fund (NYSE: JCO) today announced new details concerning its liquidation. Consistent with its investment objectives and…
4 years ago businesswire.com
Nuveen Credit Opportunities 2022 Target Term Fund Announces Wind-Up Period
NEW YORK--(BUSINESS WIRE)--The Nuveen Credit Opportunities 2022 Target Term Fund (NYSE: JCO) has entered the wind-up period in anticipation of its termination date. The fund is a “target term” fund…
5 years ago seekingalpha.com
CEF Weekly Market Review: Beware Of The Free CEF Lunch
We review CEF market valuation and performance over the third full week of October and highlight recent market events. Equity-linked CEF sectors have been supported by strength in equities while…
5 years ago seekingalpha.com
CEF Weekly Market Review: The Everything Rally
We review CEF market valuation and performance over the first week of June and highlight recent events. The CEF market pushed higher at the start of June with a favorable backdrop of stable Treasury…
5 years ago seekingalpha.com
The Quality Closed-End Fund Report, February 2021
Only funds with coverage >100% are considered.
5 years ago seekingalpha.com
The Quality Closed-End Fund Report, January 2021
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. The top DxY funds are NHF, ARDC and KIO.
6 years ago businesswire.com
Certain Nuveen Closed-End Funds Announce the Board’s Approval of Amended and Restated By-Laws of the Funds
NEW YORK--(BUSINESS WIRE)--Nuveen: Nuveen AMT-Free Municipal Credit Income Fund (NYSE: NVG), Nuveen AMT-Free Municipal Value Fund (NYSE: NUW), Nuveen AMT-Free Quality Municipal Income Fund (NYSE:…
6 years ago seekingalpha.com
The Chemist's Quality Closed-End Fund Report: August 2020
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given.
6 years ago seekingalpha.com
A Cyclical Rotation In Corporate Credit
The sudden stop to markets induced by COVID-19 caused a substantial repricing of credit risk globally, and central banks, treasuries, and ministries of finance around the world responded…
6 years ago seekingalpha.com
Changing Credit Views Amid Volatility
We downgrade investment grade credit to neutral and increase our overweight in high yield as we see volatility rising after a rally in risk assets.
6 years ago businesswire.com
Nuveen Announces Update to Closed-End Fund Portfolio Management Teams
NEW YORK--(BUSINESS WIRE)--Portfolio manager responsibilities for twelve closed-end funds have been updated. Michael Ainge, Anders Persson, Bernard Wong and Jenny Rhee are being removed as portfolio…
6 years ago marketwatch.com
Look what happened to home prices when the coronavirus sent stocks into a bear market
Residential real estate turns out to be a solid portfolio diversifier, writes Mark Hulbert.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Wednesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018